Advertisement
New Zealand markets close in 3 hours 39 minutes
  • NZX 50

    11,878.42
    +75.14 (+0.64%)
     
  • NZD/USD

    0.5946
    +0.0012 (+0.20%)
     
  • NZD/EUR

    0.5549
    +0.0008 (+0.14%)
     
  • ALL ORDS

    7,978.50
    +40.60 (+0.51%)
     
  • ASX 200

    7,723.30
    +39.80 (+0.52%)
     
  • OIL

    83.35
    -0.01 (-0.01%)
     
  • GOLD

    2,334.00
    -8.10 (-0.35%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • NIKKEI 225

    38,287.14
    +734.98 (+1.96%)
     
  • NZD/JPY

    91.9610
    +0.1950 (+0.21%)
     

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? Teva Pharmaceutical Industries (TEVA) has a debt of $34 billion on its balance sheet. The company is focused on reducing its net debt obligations to optimum levels over the coming years.